Johnson & Johnson’s 2008 sales were $63.7 billion, an increase of 4.3% over 2007. Operational growth was 1.9%, with currency contributing 2.4%. Domestic sales decreased 0.4%, while international sales increased 9.7%, reflecting operational growth of 4.6%.
Worldwide sales in the fourth quarter of 2008 were $15.2 billion, a decrease of 4.9% as compared to the fourth quarter of 2007. Operational results declined 1% and the negative impact of currency was 3.9%. Domestic sales decreased 6.9%, while international sales dropped 2.7%, reflecting operational growth of 5.4%,.
Net earnings for the year were $12.9 billion, while net earnings for the fourth quarter of 2008 were $2.7 billion. Last year’s net earnings were not released in the report to offer a percentage comparison.
According to the company, sales for the year reflect the strong performance of skin care lines Neutrogena, Aveeno and Clean & Clear; international sales of baby care products; and Listerine antiseptic mouthrinse.
Also contributing to growth were sales from the recently completed acquisition of Dabao, a leading moisturizer in China, according to the company in its report.